Reply to A.R. Khaki et al

Affiliations

Comment

Brian Hemendra Ramnaraign. JCO Oncol Pract. 2021 Sep.

. 2021 Sep;17(9):584-586.

doi: 10.1200/OP.21.00484. Epub 2021 Jul 23.

No abstract available

Comment on

Immunotherapy Management in Special Cancer Patient Populations.
Ramnaraign BH, Chatzkel JA, Al-Mansour ZA, Rogers S, Jones D, DeRemer D, George TJ. Ramnaraign BH, et al. JCO Oncol Pract. 2021 May;17(5):240-245. doi: 10.1200/OP.20.00996. Epub 2021 Mar 12. JCO Oncol Pract. 2021. PMID: 33710933 Review.
Immunotherapy in Patients With Poor Performance Status: The Jury Is Still Out on This Special Population.
Khaki AR, Glisch C, Petrillo LA. Khaki AR, et al. JCO Oncol Pract. 2021 Sep;17(9):583-586. doi: 10.1200/OP.21.00397. Epub 2021 Jul 23. JCO Oncol Pract. 2021. PMID: 34297600 No abstract available.